Clinical Value of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Term Neonates with Infection or Sepsis: A Prospective Study
Saved in:
Main Authors: | Tania Siahanidou, Alexandra Margeli, Chrysanthi Tsirogianni, Stavroula Charoni, Maria Giannaki, Eustathios Vavourakis, Athina Charisiadou, Ioannis Papassotiriou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/375702 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
by: Wenwen Zhang, et al.
Published: (2024-12-01) -
The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
by: Fei Huang, et al.
Published: (2020-01-01) -
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
by: Ranadheer R. Dande, et al.
Published: (2017-01-01) -
Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes
by: Fatima Ali Essa Al-Sudani, et al.
Published: (2024-01-01) -
Neonatal Sepsis and Inflammatory Mediators
by: Juliana Reis Machado, et al.
Published: (2014-01-01)